SYLVIA KELLY: Open Payments
NPI 1255183109 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $107 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $74 |
| PFIZER INC. | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| ABIOMED | 1 | $38 |
| Boston Scientific Corporation | 1 | $36 |
| Novo Nordisk Inc | 2 | $35 |
| SCPHARMACEUTICALS INC. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| CVRx, Inc. | 1 | $13 |
Products named: ELIQUIS, VYNDAQEL, VERQUVO, LUX-Dx Insertable Cardiac Monitor, Wegovy, FUROSCIX, CAMZYOS, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
